Structural & Congenital Heart Disease

Cardiac surgery doesn’t offer any benefit over medical treatment with antibiotics in transcatheter aortic valve replacement (TAVR) patients who have infective endocarditis (IE), researchers reported in the Journal of the American Heart Association this month.

Despite its relative rarity in clinical practice, the Ross procedure provides a survival benefit over mechanical aortic valve replacement in young and middle-aged patients, suggests a meta-analysis published in JAMA Cardiology and presented at the European Society of Cardiology (ESC) Congress in Munich.

Patients with valvular heart disease were significantly less likely to receive transthoracic echocardiograms (TTEs) within guideline-recommended timeframes if they were women, black, older or used Medicaid insurance, according to a single-center study published in JACC: Cardiovascular Imaging.

More frequent chest x-ray screenings of children with epicardial pacemakers may help identify those at risk of coronary artery compression, according to the authors of a study published online Aug. 13 in HeartRhythm.

The Cleveland Clinic was named the top hospital in the country for cardiology and heart surgery by the U.S. News & World Report—a distinction it has held since 1995.

Investor’s Business Daily published a profile of Johns Hopkins physician Helen Brooke Taussig, MD, who overcame an initial rejection to medical school due to gender discrimination and went on to create the field of pediatric cardiology.

Adult congenital heart disease (ACHD)-related heart failure (HF) hospitalizations have increased in recent years and are associated with disproportionately higher costs, procedural burden and health resource use, according to new research published in the Journal of the American Heart Association.

Patients without electrocardiographic (ECG) evidence of left ventricular hypertrophy were significantly more likely to die in the two years after transcatheter aortic valve replacement (TAVR), researchers reported July 30 in Clinical Cardiology.

More than three-fourths of patients who received percutaneous balloon mitral valvuloplasty (PBMV) at a center in Brazil maintained procedural benefit over a median follow-up of 8.3 years, researchers reported in JACC: Cardiovascular Interventions.

CMS’s advisory committee appears to be split on whether procedural volume requirements should be required for centers to begin and maintain transcatheter aortic valve replacement (TAVR) programs.

Harvard University bioengineers have created a 3D model of a human’s left ventricle that they believe could be used to test drugs and study diseases.

Researchers from Weill Cornell Medicine in New York are worried the extension of transcatheter aortic valve replacement (TAVR) to younger, intermediate-risk patients is outpacing clinical evidence.